LBA1 A randomized multicenter open label phase III trial comparing enzalutamide vs a combination of Radium-223 (Ra223) and enzalutamide in asymptomatic or mildly symptomatic patients with bone metastatic castration-resistant prostate cancer (mCRPC): First results of EORTC-GUCG 1333/PEACE-3
| Autor: | Gillessen, S., Choudhury, A., Saad, F., Gallardo, E., Soares, A., Loriot, Y., McDermott, R.S., Rodriguez-Vida, A., Isaacson, P., Nolè, F., Melo Cruz, F.J.S., Roumeguere, T., Daugaard, K.G., Yamamura, R., Lecouvet, F., Coens, C., Fournier, B., Tombal, B. |
|---|---|
| Zdroj: | In Annals of Oncology September 2024 35 Supplement 2:S1254-S1254 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|